CH200932A - Process for the pure representation of compounds of the androsten series. - Google Patents
Process for the pure representation of compounds of the androsten series.Info
- Publication number
- CH200932A CH200932A CH200932DA CH200932A CH 200932 A CH200932 A CH 200932A CH 200932D A CH200932D A CH 200932DA CH 200932 A CH200932 A CH 200932A
- Authority
- CH
- Switzerland
- Prior art keywords
- compounds
- ketone
- condensation product
- series
- androstenolone
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 9
- 150000001875 compounds Chemical class 0.000 title claims description 8
- GCKMFJBGXUYNAG-HLXURNFRSA-N Methyltestosterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 GCKMFJBGXUYNAG-HLXURNFRSA-N 0.000 title description 2
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 claims description 8
- 150000002576 ketones Chemical class 0.000 claims description 8
- 229960002847 prasterone Drugs 0.000 claims description 8
- 239000007859 condensation product Substances 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 150000001443 androstenes Chemical class 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical class OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 150000007659 semicarbazones Chemical class 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 description 2
- XUGISPSHIFXEHZ-UHFFFAOYSA-N 3beta-acetoxy-cholest-5-ene Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 XUGISPSHIFXEHZ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical class O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- HCSLNADOSCUMNR-QAZDTZPMSA-N [(3S,8S,9S,10R,13S,14S,17R)-16,16-dibromo-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate Chemical compound C(C)(=O)O[C@@H]1CC2=CC[C@H]3[C@@H]4CC([C@@H]([C@]4(CC[C@@H]3[C@]2(CC1)C)C)[C@H](C)CCCC(C)C)(Br)Br HCSLNADOSCUMNR-QAZDTZPMSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- IYYXRVUUBHBXGF-UHFFFAOYSA-N acetic acid;aminourea Chemical compound CC(O)=O.NNC(N)=O IYYXRVUUBHBXGF-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 description 1
- 229960005471 androstenedione Drugs 0.000 description 1
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- XUGISPSHIFXEHZ-VEVYEIKRSA-N cholesteryl acetate Chemical compound C1C=C2C[C@@H](OC(C)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 XUGISPSHIFXEHZ-VEVYEIKRSA-N 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- BRWIZMBXBAOCCF-UHFFFAOYSA-N hydrazinecarbothioamide Chemical compound NNC(N)=S BRWIZMBXBAOCCF-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Chemical class 0.000 description 1
- 239000011707 mineral Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- SRVJKTDHMYAMHA-WUXMJOGZSA-N thioacetazone Chemical compound CC(=O)NC1=CC=C(\C=N\NC(N)=S)C=C1 SRVJKTDHMYAMHA-WUXMJOGZSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Description
Verfahren zur Reindarstellung von Verbindungen der Androstenreihe. Gegenstand vorliegender Erfindung ist ein Verfahren zur Reindarstellung von Ver bindungen der Androstenreihe, z. B. der un gesättigten Ogyketone der Cyclopentanohy- drophenanthrenreihe, wie Dehydroandroste- ron, Testosteron u. a., oder sich von ihnen ableitenden ungesättigten Diketone, z. B. Androstendion.
Das Verfahren ist dadurch gekennzeich net, dass man ein Gemisch, welches minde stens eine der genannten Verbindungen ent hält, mit Ketonreagenzien umsetzt, das Kon densationsprodukt von den nicht umgesetz ten Begleitstoffen abtrennt und aus dem so abgetrennten Ketonkondensationsprodukt, zweckmässig nach vorangegangener Frak- tionierung, das Keton wieder abspaltet.
Ein Gemisch, welches Androstenolon CiaH2s02 enthält, wird in gleicher Weise be handelt und das Androstenolon entweder nach Aufspaltung der Kondensationspro- dulde oder nach ihrer vorherigen Fraktionie- rung aus einer der erhaltenen Fraktionen isoliert.
Auf diese Weise kann man Verbindun gen, welche entweder selbst die physiologi schen Eigenschaften männlicher Keimdrüsen hormone besitzen, d. h. Stoffe, die in geeigne ter Dosierung beim Kapaun Kammwachstum, beim kastrierten Nager Regeneration des atrophierten Genitalapparates bewirken, oder die sich in solche Verbindungen leicht über führen lassen, in reiner Form erhalten. Dabei ist es unerheblich, aus welchen Quellen die Ausgangsmaterialien stammen, ob sie ani malischen, vegetabilischen oder synthetischen Ursprunges sind.
Als besonders geeignete Kondensations mittel erwiesen sich Semicarbazid und Thio- semicarbazid, die gut kristallisierende, ziem lich schwerlösliche Semi- resp. Thiosemi- carbazone bilden. Doch sind auch andere Ke- tonreagenzien brauchbar, wie sie zum Bei spiel im Patent Nr. 164367 angeführt wurden.
Beispiel: 6,5 g des neutralen Anteils, wie er zum Beispiel erhalten wird durch Oxydation von Dibromcholesterinacetat mittels Chromsäure, Abspaltung des Broms durch Behandlung mit Zinkstaub und Eisessig und Entfernung des unzersetzten Cholesterinacetats, werden in 20 cm' Äthylalkohol gelöst. Dieser Lösung fügt man 6 g essigsaures Semicarbazid zu und erwärmt schwach. Es bildet sieh ungefähr 1 g eines Semicarbazons, das aus Chloroform- Methylalkohol umkristallisiert werden kann.
Sein Schmelzpunkt liegt bei ungefähr 267 C unter Zersetzung. Die Substanz ist das Semi- carbazon des Dehydroandrosteronacetats.
Das Semicarbazon wird mit wässriger Oxalsäure oder Mineralsäuren aufgespalten. Verseift man dieses Spaltungsprodukt mit alkoholischer Alkalihydroxydlösung, so er hält man das reine ungesättigte Oxyketon der Formel C19H"02, das Dehydroandrosteron, welches durch Umkristallisieren aus verdünn tem Aceton in Form weisser Nadeln vom Schmelzpunkt 148 C (unkorrigiert) erhalten werden kann.
Process for the pure representation of compounds of the androsten series. The present invention is a method for the pure representation of Ver compounds of the androstene series, z. B. the un saturated ogyketones of the Cyclopentanohy- drophenanthren range, such as dehydroandrosterone, testosterone and the like. a., or unsaturated diketones derived from them, e.g. B. Androstenedione.
The process is characterized in that a mixture which contains at least one of the compounds mentioned is reacted with ketone reagents, the condensation product is separated off from the unconverted accompanying substances and from the ketone condensation product thus separated, suitably after previous fractionation, splits off the ketone again.
A mixture containing androstenolone CiaH2s02 is treated in the same way and the androstenolone is isolated from one of the fractions obtained either after splitting the condensation process or after its previous fractionation.
In this way, you can find compounds which either themselves have the physiological properties of male gonads hormones, d. H. Substances which, in suitable doses, bring about regeneration of the atrophied genital apparatus in capon comb growth, in castrated rodents, or which can easily be converted into such compounds, obtained in pure form. It is irrelevant from which sources the raw materials come, whether they are of ani malic, vegetable or synthetic origin.
Semicarbazide and thiosemicarbazide, the well crystallizing, rather poorly soluble semicarbazide, proved to be particularly suitable condensation agents. Form thiosemicarbazone. However, other ketone reagents such as those listed in patent no. 164367 can also be used.
Example: 6.5 g of the neutral component, as obtained, for example, by oxidation of dibromocholesterol acetate using chromic acid, splitting off of the bromine by treatment with zinc dust and glacial acetic acid and removal of the undecomposed cholesterol acetate, are dissolved in 20 cm of ethyl alcohol. 6 g of acetic acid semicarbazide are added to this solution and the mixture is warmed gently. It forms about 1 g of a semicarbazone that can be recrystallized from chloroform-methyl alcohol.
Its melting point is around 267 C with decomposition. The substance is the semicarbazone of the dehydroandrosterone acetate.
The semicarbazone is broken down with aqueous oxalic acid or mineral acids. If this cleavage product is saponified with alcoholic alkali metal hydroxide solution, the pure unsaturated oxyketone of the formula C19H "02, the dehydroandrosterone, which can be obtained by recrystallization from dilute acetone in the form of white needles with a melting point of 148 ° C. (uncorrected) is obtained.
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE200932X | 1934-09-15 | ||
| CH164367T | 1935-01-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH200932A true CH200932A (en) | 1938-10-31 |
Family
ID=25717960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH200932D CH200932A (en) | 1934-09-15 | 1935-01-12 | Process for the pure representation of compounds of the androsten series. |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH200932A (en) |
-
1935
- 1935-01-12 CH CH200932D patent/CH200932A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2103735A (en) | Method of isolating the follicle hormone from the urine of pregnant individuals | |
| DE699308C (en) | Process for the production of polynuclear substituted ring ketones from sterols and bile acids | |
| US2125772A (en) | Sexual hormone compositions and process of producing same | |
| CH197780A (en) | Process for the pure preparation of keto group-containing derivatives of cyclopentanophenanthrole compounds. | |
| DE726628C (en) | Process for the preparation of saturated oxyketones | |
| DE920243C (en) | Process for the production of ª ‰ -isopropylnaphthalene | |
| DE878351C (en) | Process for the preparation of testosterone | |
| DE937349C (en) | Process for the separation and purification of ketosteroids | |
| DE709617C (en) | Process for the preparation of AEtiocholylglyoxalen | |
| DE2325652C3 (en) | Process for the production of resorcinol by cleaving m-diisopropylbenzene dihydroperoxide | |
| DE686759C (en) | andions | |
| DE883749C (en) | Process for the preparation of polyenecarboxylic acid esters by condensation of ª † -halogencrotonic acid esters with ª ‡, ª ‰ -unsaturated ketones | |
| DE748538C (en) | Process for the preparation of polynuclear substituted unsaturated ring ketones | |
| DE597261C (en) | Process for the preparation of hydrogenation products of the follicular hormone | |
| DE926129C (en) | Process for the rearrangement of O-acetylacetoacetic ester into C-acetylacetoacetic ester | |
| DE725280C (en) | Process for the preparation of compounds of the cyclopentanopolyhydrophenanthrene series | |
| DE562007C (en) | Process for the production of monoethyl ethers of protocatechualdehyde | |
| DE695638C (en) | Process for the preparation of a diketone of the cyclopentanohydrophenanthrene series | |
| DE699127C (en) | Method of obtaining male and corpus | |
| AT160622B (en) | Process for the preparation of oxyoxo or polyoxy compounds of the cyclopentanopolyhydrophenanthrene series which do not contain any phenolic hydroxyl groups. | |
| DE725742C (en) | Process for the preparation of ª ‡ -dicarbonyl compounds of the cyclopentanopolyhydrophenanthrene series | |
| AT124273B (en) | Method for the preparation of vanillin and a vanillin homolog. | |
| DE965637C (en) | Process for the preparation of 19-nortestosterone-17-acylates and / or their 3-enol acylates | |
| DE733297C (en) | Process for the preparation of partially or completely degraded oxidation products of compounds of the cyclopentanohydrophenanthren series in the side chain | |
| DE870404C (en) | Process for the preparation of ketols of the cyclopentanopolyhydrophenanthrene series |